The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in new crops and new uses
Janick, J., & Whipkey, A. (2002) · Cited by 1,404
Davin, L. B., Wang, H.-B., Crowell, A. L., Bedgar, D. L., Martin, D. M., Sarkanen, S., & Lewis, N. G. (1997) · Science · doi:10.1126/science.275.5298.362 · Cited by 755
Giri, A., & Narasu, M. L. (2000) · Biotechnology Advances · doi:10.1016/s0734-9750(99)00016-6 · Cited by 575
Lignans; chemical, biological and clinical properties
(1991) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(91)90216-y · Cited by 376
Lignans, neolignans and related compounds
Ward, R. S. (1999) · Natural Product Reports · doi:10.1039/a705992b · Cited by 357
Imbert, T. F. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80004-7 · Cited by 350
Lignans, neolignans, and related compounds
Ward, R. S. (1995) · Natural Product Reports · doi:10.1039/np9951200183 · Cited by 325
Nomenclature of Lignans and Neolignans (IUPAC Recommendations 2000)
Moss, G. P. (2000) · Pure and Applied Chemistry · doi:10.1351/pac200072081493 · Cited by 293
Antitumor Properties of Podophyllotoxin and Related Compounds
Gordaliza, M., Castro, M., Miguel del Corral, J., & San Feliciano, A. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003398582 · Cited by 268
Self-citation(−)-Arctigenin as a Lead Structure for Inhibitors of Human Immunodeficiency Virus Type-1 Integrase
Eich, E., Pertz, H., Kaloga, M., Schulz, J., Fesen, M. R., Mazumder, A., & Pommier, Y. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950387u · Cited by 203
Whiting, D. A. (1985) · Natural Product Reports · doi:10.1039/np9850200191 · Cited by 172
Propagation and conservation of Podophyllum hexandrum Royle: an important medicinal herb
Nadeem, M., Palni, L. M. S., Purohit, A. N., Pandey, H., & Nandi, S. K. (2000) · Biological Conservation · doi:10.1016/s0006-3207(99)00059-2 · Cited by 168
Secoisolariciresinol Dehydrogenase Purification, Cloning, and Functional Expression
Xia, Z.-Q., Costa, M. A., Pélissier, H. C., Davin, L. B., & Lewis, N. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008622200 · Cited by 162
Bindra, J. S., & Lednicer, D. (1982) · American Chemical Society eBooks · Cited by 149
Current status and future strategy for development of medicinal plants sector in Uttaranchal, India
Dhar, U., Manjkhola, S., Joshi, M. Y., Bhatt, A., Bisht, A., & Joshi, M. (2002) · Cited by 146
Production of Podophyllotoxin by Plant Cell Cultures of Podophyllum hexandrum in Bioreactor
Chattopadhyay, S., Srivastava, A. K., Bhojwani, S. S., & Bisaria, V. S. (2002) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(02)80017-2 · Cited by 135
Lignans, neolignans, and related compounds
Whiting, D. A. (1987) · Natural Product Reports · doi:10.1039/np9870400499 · Cited by 133
Lignans; chemical, biological and clinical properties
(1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90258-8 · Cited by 121
Lignans, neolignans, and related compounds
Whiting, D. A. (1990) · Natural Product Reports · doi:10.1039/np9900700349 · Cited by 100
In Vitro Evaluation of Antifungal Properties of 8.O.4‘-Neolignans
Zacchino, S. A., Rodríguez, G., Pezzenati, G., Orellana, G. A., Enriz, R. D., & Sierra, M. G. (1997) · Journal of Natural Products · doi:10.1021/np9605504 · Cited by 96
van Uden, W., Pras, N., & Malingré, T. M. (1990) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/bf00034435 · Cited by 85
Mittal, A., PATHANIA, V., Agrawala, P. K., Prasad, J., Singh, S. K., & Goel, H. C. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(01)00243-4 · Cited by 75
Tseng, C.-J., Wang, Y.-J., Liang, Y., Jeng, J., Lee, W., Lin, J., Chen, C.-H., Liu, I., & Ho, Y. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00073-2 · Cited by 73
Inhibitory Effects of Podophyllotoxin Derivatives on Herpes Simplex Virus Replication
Sudo, K., Konno, K., Shigeta, S., & Yokota, T. (1998) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029800900307 · Cited by 73
Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents
Subrahmanyam, D., Renuka, B., Rao, C. V., Sagar, P., Deevi, D. S., Babu, J. M., & Vyas, K. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00232-7 · Cited by 64
Natural Products as Leads for New Pharmaceuticals
Buss, A. D., Cox, B. J., & Waigh, R. D. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc018 · Cited by 54
Kamal, A., Laxman, N., & Ramesh, G. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00407-8 · Cited by 54
Cardiovascular activity of naturally occurring lignans
Ghisalberti, E. L. (1997) · Phytomedicine · doi:10.1016/s0944-7113(97)80063-3 · Cited by 49
Khurdayan, V. K., Bozzo, J., & Sorbera, L. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.4.915730 · Cited by 49
Antibiotic resistance versus small molecules, the chemical evolution
LEE, V. J., & Hecker, S. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199911)19:6<569::aid-med7>3.0.co;2-9 · Cited by 46
Tetrahydronaphthalene Lignan Compounds as Potent Anti-HIV Type 1 Agents
Hara, H., FUJIHASHI, T., SAKATA, T., Kaji, A., & Kaji, H. K. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.695 · Cited by 41
Synthesis, cytotoxicity and antiviral activity of podophyllotoxin analogues modified in the E-ring
CASTRO, M. A. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.05.001 · Cited by 40
Self-citationDaley, L., Guminski, Y., Demerseman, P., Kruczynski, A., Etiévant, C., Imbert, T., Hill, B. T., & Monneret, C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800752 · Cited by 39
Lee, C.-C., & Huang, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011048831698 · Cited by 28
Protection against radiation induced damage to spermatogenesis by Podophyllum hexandrum
Samanta, N., & Goel, H. C. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00081-8 · Cited by 26
Carlström, P.-J. H. K. (2000) · Scandinavian Journal of Rheumatology · doi:10.1080/030097400750001888 · Cited by 26
Conformational Properties of α-Tubulin Tail Peptide: Implications for Tail−Body Interaction
Pal, D., Mahapatra, P. K., Manna, T. K., Chakrabarti, P., Bhattacharyya, B., Banerjee, A., Basu, G., & Roy, S. (2001) · Biochemistry · doi:10.1021/bi015677t · Cited by 25
Useful plants of dermatology. VI. The mayapple (Podophyllum)
Schwartz, J. R., & Norton, S. A. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.125081 · Cited by 12
Modified CoMFA methods for the analysis of antineoplastic effects of lignan analogues
Broughton, H. B., Gordaliza, M., CASTRO, M. A., et al. (2000) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(00)00369-9 · Cited by 7
Self-citationTachibana, Y., Zhu, X., Krishnan, P., Lee, K., & Bastow, K. F. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200001000-00004 · Cited by 5
Synthesis of Imidazo[4,5-d]oxazolo[3,4-a]pyridines. New Heterocyclic Analogues of Lignans
Madrigal, B., Puebla, P., Caballero, E., Peláez, R., Grávalos, D. G., & Medarde, M. (2001) · Archiv der Pharmazie · doi:10.1002/1521-4184(200105)334:5<177::aid-ardp177>3.0.co;2-k · Cited by 5
Cited by
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
Natural products as leads to anticancer drugs
Gordaliza, M. (2007) · Clinical and Translational Oncology · doi:10.1007/s12094-007-0138-9 · Cited by 701
Self-citationRamirez-Estrada, K., Vidal-Limon, H., Hidalgo, D., Moyano, E., Golenioswki, M., Cusidó, R., & Palazon, J. (2016) · Molecules · doi:10.3390/molecules21020182 · Cited by 608
Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone
Lau, W., & Sattely, E. S. (2015) · Science · doi:10.1126/science.aac7202 · Cited by 470
Pimentel, M. R., Molina, G., Dionísio, A. P., Maróstica Junior, M. R., & Pastore, G. M. (2011) · Biotechnology Research International · doi:10.4061/2011/576286 · Cited by 277
Metadata
- Authors
- Gordaliza, M., Garcı́a, P. A., Miguel del Corral, J. M., Castro, M. A., & Gómez-Zurita, M. A.
- Venue
- Toxicon
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 44
- Issue
- 4
- Pages
- 441-459
- ISSN
- 0041-0101 (ISSN-L)
- OpenAlex
- W1991278633
- Cited by
- 548
- References
- 41
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.